Biocide TRIZ Cases

A Panax ginseng cambium stem cell composition inhibits hepatitis virus proliferation and enhances immune response.

Formula I compounds inhibit NS5A protein function to treat Hepatitis C virus infection while reducing side effects from existing therapies.

Replacing diphosgene with carbonyldiimidazole eliminates hazardous intermediates and reduces synthesis time for triazinon-benzoxazinones.

Combines cyclooxygenase-2 inhibitors with acetylsalicylic acid to prevent migraine symptoms.

Heteroaryl-modified Formula I compounds inhibit ERK kinase activity, reducing off-target effects while maintaining therapeutic effectiveness.

Chitosan and alginate biopolymer capsules encapsulate essential oils, preventing UV radiation degradation that reduces larvicidal efficacy in mosquito control.

Isoxazolidine derivatives with defined structural formulas enhance insecticidal efficacy against diverse pests.

Compounds selectively bind Bcl-xL to reset apoptotic pathways, avoiding off-target toxicity in normal cells.

Lactobacillus plantarum MG4229 lowers blood glucose by inhibiting alpha-glucosidase, avoiding drug side effects.

A dual-substrate emanation system delivers staged active ingredient release via microemulsion diffusion.

Urea glucokinase activators improve glycemic control by activating the glucokinase enzyme, addressing inadequate blood sugar management in type 2 diabetes.

An electrical connection device integrates a contact plug with an actuator coil and temperature sensor interface within a single housing unit.

A composite herbal dressing combines Plectranthus amboinicus and Centella asiatica extracts to enhance diabetic wound healing while lowering treatment costs.

A CPS1 mutant fungal strain elicits protective immune responses against coccidioidomycosis.

Antibacterial resin composition incorporates fatty acid metal salts to elute silver ions efficiently, reducing cost while maintaining stability.

Solid catalysts convert lycopene to stable Z-isomers, resolving the trade-off between thermal isomerization efficiency and product stability.

Organic solvent wet granulation overcomes poor compressibility and hygroscopicity to produce robust aliskiren tablets with high drug loading.

A biodegradable carrier dispenser releases active insect control ingredients at a controlled rate.

Formula I compounds resist thermal degradation and chemical inactivation to maintain antimicrobial activity at elevated temperatures.

A trans-2-decenoic acid derivative activates the MAP kinase signaling pathway to promote nerve cell survival.

Pelubiprofen oral formulations use 1 to 30 μm particle sizing with specific additives to achieve high bioavailability and rapid pharmacological effects.

A resilient porous applicator carries freeze-dried antimicrobial compounds reconstituted by delivery fluid.

Ortho-fluorine substituted diaminotriazine compounds achieve effective weed control at low application rates while maintaining crop plant compatibility.

Protocatechuic acid deposits a crystalline coating that physically disrupts viral structures on contact.

Dispersing hyaluronic acid in an acidic water-containing medium reduces molecular weight without browning, enabling stable cosmetic and food formulations.

Adjusting HMG-CoA synthase and reductase activity prevents toxicity while maintaining robust cell growth and productivity.

Formula I macrocycles resolve the efficacy versus side effect trade-off in hepatitis C treatment by targeting NS5B with improved selectivity.

Substituted phenyl-pyridazine-diones deliver targeted herbicidal activity against broad-leaved dicotyledonous weeds.

A 2-alkynyl-N9-propargyladenine compound acts as a potent adenosine A2a receptor antagonist.

A filamin A-binding compound stabilizes mu opioid receptor signaling to deliver sustained analgesia.

Combination therapy regulates HPA axis and prefrontal cortex activity to reduce relapse likelihood in addiction treatment.

Topical dsRNA application silences the acetolactate synthase gene, restoring herbicide sensitivity to resistant weed biotypes.

R-Pro9-3 nonameric peptide penetrates bacterial membranes via electrostatic interactions and hydrophobic effects.

Biradical polarizing agents merge nitroxide moieties with solubilizing linkers to boost NMR signal enhancement while maintaining aqueous media compatibility.

Applying acetate-based disruptants after first-generation oviposition reduces active component loss while maintaining high-density pink bollworm control.

Combining imazamox with prohexadione or trinexapac inhibits ethylene perception, reducing host plant damage while controlling Orobanche infestations.

A suspension concentrate formulation stabilizes sulfonylurea herbicides in oil using non-ionic block copolymers and surfactants.

Imidazole compounds inhibit tyrosine kinase enzymes, reducing treatment complexity while enhancing efficacy.

Hydroalcoholic formulations accelerate permucosal paracetamol uptake, bypassing hepatic first-pass metabolism to ensure immediate systemic circulation.

PolyAgro block copolymers and non-ionic surfactants prevent caking, sedimentation, and crystal growth in high load suspension concentrates.

Folates reverse eNOS uncoupling by increasing vascular BH4 levels, resolving oxidative stress trade-offs in cardiovascular therapy.

Merges flazasulfuron with protoporphyrinogen oxidase inhibitors to overcome narrow-spectrum limitations and achieve prolonged weed control.

Amide compounds target alpha4beta2 receptors to treat cognitive disorders while avoiding cardiovascular side effects.

Recombinant E. coli with modified disulfide reductase activity produces soluble CRM197 protein.

Segmented cytotoxic compounds attach to targeting molecules via self-immolative linkers, resolving nonselective toxicity in anticancer treatments.

A herbicidal composition combines sulfonylurea compounds with polyoxyalkylene alkyl ether phosphate to improve weed control efficacy.

Combining A122T and A205V AHASL1 alleles enables sunflower crop safety against imidazolinone herbicides.